SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : North American Vaccine
NVX 0.985-5.3%Jan 30 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Don W Stone who wrote (184)12/24/1997 9:40:00 PM
From: David Bogdanoff  Read Replies (4) of 507
 
DS and all;

I would be very pleased to see a spike in NVX upon the long awaited FDA approval, but my expectations are not so high because I have been
following other small drug companies that did not spike when expected good news materialized recently. This occured with Ligand when a product was approved and with Vivus when a UK marketing approval came through. A few weeks later, both stocks are double digits lower :( .
The expected good news was surely built into the stocks since both events were anticipated for months.

David
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News